These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34599890)

  • 1. Immunosuppressive CD14
    Viana CEM; Matos DM; Oliveira MF; da Costa AC; Filho TPA; Filho PAM; Nunes FMM; Nogueira Dos Santos T; Gonçalves RP; Queiroz JAN
    Acta Trop; 2021 Dec; 224():106154. PubMed ID: 34599890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
    Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
    J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity.
    Souza PE; Rocha MO; Rocha-Vieira E; Menezes CA; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2004 Sep; 72(9):5283-91. PubMed ID: 15322024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
    Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
    [No Abstract]   [Full Text] [Related]  

  • 5. The CD14
    Mengos AE; Gastineau DA; Gustafson MP
    Front Immunol; 2019; 10():1147. PubMed ID: 31191529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease.
    Pinto BF; Medeiros NI; Teixeira-Carvalho A; Eloi-Santos SM; Fontes-Cal TCM; Rocha DA; Dutra WO; Correa-Oliveira R; Gomes JAS
    Front Immunol; 2018; 9():454. PubMed ID: 29599775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.
    Tian T; Gu X; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
    Cancer Biomark; 2015; 15(4):425-32. PubMed ID: 25792471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation.
    Asmussen A; Busch HJ; Helbing T; Bemtgen X; Smolka C; Bode C; Fink K; Grundmann S
    Sci Rep; 2021 Jun; 11(1):12403. PubMed ID: 34117334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated frequencies of CD14
    Xue G; Jiang M; Zhao R; Le A; Li J
    Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens.
    Soares AK; Neves PA; Cavalcanti MD; Marinho SM; Oliveira W; Souza JR; Lorena VM; Gomes YM
    Rev Soc Bras Med Trop; 2016; 49(5):632-636. PubMed ID: 27812661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass.
    Quimby KR; Greenidge A; Harris A; Landis RC
    Cytometry B Clin Cytom; 2010 Sep; 78(5):357-60. PubMed ID: 20533393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
    Vuk-Pavlović S; Bulur PA; Lin Y; Qin R; Szumlanski CL; Zhao X; Dietz AB
    Prostate; 2010 Mar; 70(4):443-55. PubMed ID: 19902470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD14(+) HLA-DR low/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma.
    Khalifa KA; Badawy HM; Radwan WM; Shehata MA; Bassuoni MA
    Int J Lab Hematol; 2014 Dec; 36(6):650-5. PubMed ID: 24636145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
    Du J; Sun X; Song Y
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive monocytes (CD14
    Lima DS; Lemes RPG; Matos DM
    Med Oncol; 2018 Feb; 35(3):36. PubMed ID: 29429058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
    Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
    Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.